More than Lady Luck for Ovarian Cancer
Did you know that 75% of women with ovarian cancer recur and the chance for these patients to enjoy a cure is less than 15%? That's less than the odds around most poker tables and the stakes are a lot higher. The Clearity Foundation would like to thank Blueprint Life Science Group and CMEA Capital for hosting a Texas Hold‘Em poker tournament in support of The Clearity Foundation. We would also like to thank the more than 50 people who enjoyed a fun evening and who re-bought chips not only seeking out the first place prize but as a donation to The Clearity Foundation!
Ovarian cancer is a complex, heterogeneous disease where most all women receive standard carboplatin/paclitaxel treatment, regardless of the histology or the molecular biology of their tumors. Ovarian cancer kills more than 15,000 women every year out of the approximately 21,000 diagnosed. When a patient’s ovarian cancer returns after standard chemotherapy, a chance for a cure is less than 15%, or less than 3% if she did not respond to initial treatment. The mission of The Clearity Foundation is to improve treatment options for ovarian cancer patients and change the one-size-fits-all approach in order to improve survival. The Clearity Foundation is a 501(c)(3) not-for-profit organization.
